CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Rhelion Life Sciences Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Rhelion Life Sciences Corp
1 Adelaide Street East, Suite 801
Phone: (604) 204-7129p:604 204-7129 TORONTO, ON  M5C 2V9  Canada Ticker: RHELRHEL
Business Summary
Rhelion Life Sciences Corp., formerly Red Light Holland Corp., is a science and research led company advancing the natural psychedelic drug discovery and development sector. Through its wholly owned subsidiary Filament Health Corp., the Company is developing naturally derived psilocybin drug candidates, including its patented PEX010, and supporting clinical research and compassionate use programs with institutions around the world. PEX010 is its standardized natural psilocybin drug candidate, studied across 80+ clinical trials worldwide, including FDA-authorized programs in depression, PTSD, cancer-related distress, and substance use disorders. Its products also include IBEXX and MB2500. IBEXX is its botanical ibogaine drug candidate. MB2500 is its whole-leaf coca extract drug candidate. It also operates in the Netherlands' legal adult-use market and supports voluntary data collection and research to help advance the scientific understanding of natural psychedelics.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20263/31/2026Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2833 Medicinal chemicals and botanical products
0182 Food crops grown under cover

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Brad J.Lamb 1/1/2022 5/25/2020
Chief Executive Officer, Director ToddShapiro 5/22/2020 5/22/2020
President of RLH Netherlands B.V. HansDerix
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Filament Health Corp 210-4475 Wayburne Drive BURNABY BC Canada

Business Names
Business Name
4YX
Filament Health Corp
Radix Motion Inc.
RELH
RHEL
TRIP

General Information
Outstanding Shares: 576,504,192 (As of 6/12/2026)
Stock Exchange: CNQ


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, August 16, 2026